Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis - PubMed (original) (raw)

Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis

C Giordano et al. Science. 1997.

Abstract

The mechanisms responsible for thyrocyte destruction in Hashimoto's thyroiditis (HT) are poorly understood. Thyrocytes from HT glands, but not from nonautoimmune thyroids, expressed Fas. Interleukin-1beta (IL-1beta), abundantly produced in HT glands, induced Fas expression in normal thyrocytes, and cross-linking of Fas resulted in massive thyrocyte apoptosis. The ligand for Fas (FasL) was shown to be constitutively expressed both in normal and HT thyrocytes and was able to kill Fas-sensitive targets. Exposure to IL-1beta induced thyrocyte apoptosis, which was prevented by antibodies that block Fas, suggesting that IL-1beta-induced Fas expression serves as a limiting factor for thyrocyte destruction. Thus, Fas-FasL interactions among HT thyrocytes may contribute to clinical hypothyroidism.

PubMed Disclaimer

Comment in

• Science. 1998 Mar 27;279(5359):2015
• Thyroid disease: a case of cell suicide?
  Williams N. Williams N. Science. 1997 Feb 14;275(5302):926. doi: 10.1126/science.275.5302.926. Science. 1997. PMID: 9053994 No abstract available.

Similar articles

• Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis.
  Stassi G, Todaro M, Bucchieri F, Stoppacciaro A, Farina F, Zummo G, Testi R, De Maria R. Stassi G, et al. J Immunol. 1999 Jan 1;162(1):263-7. J Immunol. 1999. PMID: 9886394
• Thyrocyte targets and effectors of autoimmunity: a role for death receptors?
  Hammond LJ, Palazzo FF, Shattock M, Goode AW, Mirakian R. Hammond LJ, et al. Thyroid. 2001 Oct;11(10):919-27. doi: 10.1089/105072501753210975. Thyroid. 2001. PMID: 11716038
• Expression and distribution of S-100 protein, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in thyroid tissues of autoimmune thyroid diseases.
  Xu WC, Chen SR, Huang JX, Zheng ZC, Chen LX, Lin JJ, Li YG. Xu WC, et al. Eur J Histochem. 2007 Oct-Dec;51(4):291-300. doi: 10.4081/1154. Eur J Histochem. 2007. PMID: 18162459
• Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease.
  Salmaso C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, Altrinetti V, Richiusa P, Galluzzo A, Giordano C. Salmaso C, et al. Ann N Y Acad Sci. 2002 Jun;966:496-501. doi: 10.1111/j.1749-6632.2002.tb04253.x. Ann N Y Acad Sci. 2002. PMID: 12114310 Review.
• Fas-FasL in Hashimoto's thyroiditis.
  Stassi G, Zeuner A, Di Liberto D, Todaro M, Ricci-Vitiani L, De Maria R. Stassi G, et al. J Clin Immunol. 2001 Jan;21(1):19-23. doi: 10.1023/a:1006732713634. J Clin Immunol. 2001. PMID: 11321234 Review.

Cited by

• The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.
  Lin Y, Cui N, Li F, Wang Y, Wang B. Lin Y, et al. Front Endocrinol (Lausanne). 2024 Apr 30;15:1330896. doi: 10.3389/fendo.2024.1330896. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38745958 Free PMC article.
• Predictive factors of lymph node metastasis in papillary thyroid cancer.
  Song WJ, Um IC, Kwon SR, Lee JH, Lim HW, Jeong YU, Chung SM, Moon JS, Yoon JS, Won KC, Lee HW. Song WJ, et al. PLoS One. 2023 Nov 27;18(11):e0294594. doi: 10.1371/journal.pone.0294594. eCollection 2023. PLoS One. 2023. PMID: 38011178 Free PMC article.
• The Impact of Nigella sativa Essential Oil on T Cells in Women with Hashimoto's Thyroiditis.
  Ciesielska-Figlon K, Wojciechowicz K, Daca A, Kokotkiewicz A, Łuczkiewicz M, Witkowski JM, Lisowska KA. Ciesielska-Figlon K, et al. Antioxidants (Basel). 2023 Jun 9;12(6):1246. doi: 10.3390/antiox12061246. Antioxidants (Basel). 2023. PMID: 37371976 Free PMC article.
• GRANULYSIN PEPTIDE AND GENE POLYMORPHISM IN THE PATHOGENESIS OF HASHIMOTO THYROIDITIS.
  Genc GC, Celik SK, Arpaci D, Aktaş T, Can M, Bayraktaroğlu T, Dursun A. Genc GC, et al. Acta Endocrinol (Buchar). 2022 Jul-Sep;18(3):288-293. doi: 10.4183/aeb.2022.288. Acta Endocrinol (Buchar). 2022. PMID: 36699164 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal